Global Cancer Supportive Care Drug Market Projected Around USD 22,760.32 Million by 2026

26-Mar-2020 | Facts and Factors

The global Cancer Supportive Care Drug market in 2019 is approximately USD 21,230.12 Million. The market is anticipated to grow at a CAGR of 1.1% and is projected to reach around USD 22,760.32 Million by 2026.

Cancer Supportive Care Drug Market

Request Sample Request Customization Buy Now

Cancer is a group of diseases, describe as abnormal cell growth which may not or may move to the other part of the body. In order to control cancer, many drug therapies are prescribed by a physician. A supportive drug is a medicine that is not the active part of therapy but is incorporated into the remedy for the better management of disorders. The various drug used as supportive drugs are G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs, and Others.

Browse the full “Cancer Supportive Care Drug Market by Product Type By Type (G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs, and Others), By Distributor Channel (Hospital, Pharmacy, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026" https://www.fnfresearch.com/cancer-supportive-care-drug-market-by-product-type-937

The cancer supportive care drug market is highly driven by an increasing number of cancer-related disorders across the world. In addition, the increasing aging population in Europe and North America is also one of the major factors driving the growth of the market. Furthermore, an increasing portion of the population with high per capita healthcare expenditures coupled with early detection is one of the major driving factors for this market. Various factors such as increasing the use of immune-oncology agents and other alternatives may restrain the growth of the market. Increasing research and development and pipeline drugs may be considered as futuristic opportunities within the forecast periods.

In product type, the market is classified into seven types G-CSFs, Opioids, Antiemetics, Bisphosphonates, ESAs, NSAIDs, and Others. At present, G-CSFs used for neutropenia (CIN), For Anemia ESAs (CIA), for nausea and vomiting; antiemetics (CINV), bisphosphonates for cancer-induced bone diseases, and NSAIDs and opioids for the treatment of cancer pain. In terms of therapeutic Class, granulocyte stimulating factors accounted for the largest market shares in the year 2019 and the same remains continuous within the forecasted year followed by opioids.

Based on end-users, the market is classified into Specialty clinics, hospitals, direct consumer,s and others. Public and Private Hospitals combined account for the largest market shares in the year 2019. This segment accounts for around more than 70% of market shares in the year 2019.

North America accounts for the largest market share in the year 2019. As per our analysis, North America accounted for more than 40% of the market share in the year 2019. Fast treatment, Public awareness, a High literacy rate, and advanced healthcare infrastructures are some of the major factors driving this region. The European Market is mainly driven by countries like the UK, Germany, France, Italy, and Spain. High per capita income is one of the major driving factors for this country. Brazil is the major driving country for the Latin America Market. Brazil contributes more than half of the revenue shares in the Latin American Region.

Report Scope

Report Attribute

Details

Market Size in 2019

USD 21,230.12 Million

Projected Market Size in 2026

USD 22,760.32 Million

CAGR Growth Rate

1.1% CAGR

Base Year

2020

Forecast Years

2020-2026

Key Market Players

Amgen, Merck, Novartis, Johnson & Johnson, Roche, Helsinn Healthcare, Heron Pharma, Tesaro, and Purdue Pharma amongst others.

Key Segment

By Distribution Channel, By Type, By Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

Some of the major players operating in Amgen, Merck, Novartis, Johnson & Johnson, Roche, Helsinn Healthcare, Heron Pharma, Tesaro, and Purdue Pharma amongst others.

This report segments the Cancer Supportive Care Drug market as follows:

Global Cancer Supportive Care Drug Market: Type Segment Analysis

  • G-CSFs
  • Bisphosphonates
  • Antiemetics
  • Opioids
  • NSAIDs
  • ESAs
  • Others

Global Cancer Supportive Care Drug Market: Distribution Channel Segment Analysis

  • Hospital
  • Pharmacy
  • Others

Global Cancer Supportive Care Drug Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction in our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com

 


Latest Market Research Reports

report img

Packaging Tubes Market Report 2024 – 2032

[209+ Pages Report] According to Facts Factors,the global packaging tubes market size was valued at USD 4.48 billion in 2023 and is predicted to surpass USD 7.33 billion by the end of 2032. The packaging tubes industry is expected to grow by a CAGR of 5.63% between 2024 and 2032. Packaging Tubes Ma

Published Date : 09-Dec-2024 | | Category : Packaging | Pages : 209 | Format : Read more

Inquiry for Buying Request Sample
report img

Digital Content Creation Market Report 2024 – 2032

[216+ Pages Report] According to Facts Factors,the global digital content creation market size was valued at USD 30.05 billion in 2023 and is predicted to surpass USD 94.24 billion by the end of 2032. The digital content creation industry is expected to grow by a CAGR of 13.54% between 2024 and 203

Published Date : 06-Dec-2024 | | Category : Technology & Media | Pages : 216 | Format : Read more

Inquiry for Buying Request Sample
report img

Patient Safety And Risk Management Software Market Report 2024 – 2032

[215+ Pages Report] According to Facts Factors,the global patient safety and risk management software market size was valued at USD 2,140.35 million in 2023 and is predicted to surpass USD 5,378.20 million by the end of 2032. The patient safety and risk management software industry is expected to g

Published Date : 05-Dec-2024 | | Category : Technology & Media | Pages : 215 | Format : Read more

Inquiry for Buying Request Sample
report img

Fitness Tracker Market Report 2024 – 2032

[214+ Pages Report] According to Facts Factors,the global fitness tracker market size was valued at USD 53.14 billion in 2023 and is predicted to surpass USD 247.09 billion by the end of 2032. The fitness tracker industry is expected to grow by a CAGR of 18.62% between 2024 and 2032. Fitness Tracke

Published Date : 04-Dec-2024 | | Category : Technology & Media | Pages : 214 | Format : Read more

Inquiry for Buying Request Sample
report img

Financial Risk Management Software Market Report 2024 – 2032

[223+ Pages Report] According to Facts Factors,the global financial risk management software market size was valued at USD 3.15 billion in 2023 and is predicted to surpass USD 10.14 billion by the end of 2032. The financial risk management software industry is expected to grow by a CAGR of 13.89% b

Published Date : 03-Dec-2024 | | Category : Technology & Media | Pages : 223 | Format : Read more

Inquiry for Buying Request Sample

Why FnF Market Research?

1 Inflallible Methodology

to ensure high-level data integrity, accurate analysis, and impeccable forecasts

2 Analyst Support

for complete satisfaction

3 Customization

on-demand customization of scope of the report to exactly meet your needs

4 Targeted Market View

Targeted market view to provide pertinent information and save time of readers

5 Agile Approach

A faster and efficient way to cater to the needs with continuous iteration